1 / 10

Aarkstore - Visceral Pain - Pipeline Review, H2 2014

This report provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ http://goo.gl/3O9fjz

kaveriRai9023
Download Presentation

Aarkstore - Visceral Pain - Pipeline Review, H2 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthcare Market Research Report Visceral Pain - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

  2. Summary Visceral Pain - Pipeline Review, H2 2014, provides an overview of the Visceral Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Visceral Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Visceral Pain and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.  For More Information Visit : www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Visceral Pain- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Visceral Pain and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Visceral Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages Browse full report or Sample Request @ • http://www.aarkstore.com/pharmaceuticals-healthcare/100598/visceral-pain-pipeline-review-h2-2014 For More Information Visit : www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Visceral Pain- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

  5. Table of Content IntroductionREPORT COVERAGEVisceral Pain OverviewTherapeutics DevelopmentPipeline Products for Visceral Pain - OverviewPipeline Products for Visceral Pain - Comparative AnalysisVisceral Pain - Therapeutics under Development by CompaniesVisceral Pain - Pipeline Products GlanceClinical Stage ProductsEarly Stage ProductsVisceral Pain - Products under Development by CompaniesVisceral Pain - Companies Involved in Therapeutics DevelopmentNektar TherapeuticsAstellasPharma Inc.Neurim Pharmaceuticals LtdGrunenthal GmbH For More Information Visit : www.aarkstore.com

  6. List of Tables Number of Products under Development for Visceral Pain, H2 2014Number of Products under Development for Visceral Pain - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Comparative Analysis by Early Stage Development, H2 2014Products under Development by Companies, H2 2014Visceral Pain - Pipeline by Nektar Therapeutics, H2 2014Visceral Pain - Pipeline by AstellasPharma Inc., H2 2014Visceral Pain - Pipeline by Neurim Pharmaceuticals Ltd, H2 2014Visceral Pain - Pipeline by Grunenthal GmbH, H2 2014Visceral Pain - Pipeline by Trevena, Inc., H2 2014Visceral Pain - Pipeline by Hydra Biosciences, Inc., H2 2014Visceral Pain - Pipeline by GIcarePharma Inc, H2 2014Visceral Pain - Pipeline by IstitutoItalianodiTecnologia, H2 2014 For More Information Visit : www.aarkstore.com

  7. List of Figures Number of Products under Development for Visceral Pain, H2 2014Number of Products under Development for Visceral Pain - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Top 10 Target, H2 2014Number of Products by Stage and Top 10 Target, H2 2014Number of Products by Top 10 Mechanism of Action, H2 2014Number of Products by Stage and Top 10 Mechanism of Action, H2 2014Number of Products by Stage and Top 10 Route of Administration, H2 2014Number of Products by Stage and Top 10 Molecule Type, H2 2014 For More Information Visit : www.aarkstore.com

  8. Related Reports • Intrauterine Contraceptive Devices Market (IUD/IUCD),by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019 • Asian Healthcare Workflow Systems Market by Type (Fraud Detection, Pharmacy Audit & Analysis, Claim Management System, Customer Relationship Management), by End-User - Forecast to 2019 • Healthcare IT (HIT) Market in the APAC Region 2015-2019 • Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report • Global Healthcare BPO Market 2015-2019 • Colposcopy Test, Market, Users & Forecast - Asia & Middle East Analysis • Point of Care Diagnostic Testing World Markets • Europe Laboratory Information System Market For More Information Visit : www.aarkstore.com

  9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related